Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis

Published:2019-01-21 Issue:8 Volume:54 Page:1295-1303
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gutiérrez-García Gonzalo^ORCID,Cibeira María Teresa,Rovira Montserrat,Fernández de Larrea Carlos,Tovar Natalia,Rodríguez-Lobato Luis Gerardo^ORCID,Rosiñol Laura,Marín Pedro,Solano-Vega Julio,Suárez-Lledó María,Bataller Alex^ORCID,Solano María Teresa,de Llobet Noemí,Domenech Ariadna,Borràs Nuria,Lozano Miquel,Cid Joan,Martínez Carmen,Urbano-Ispizua Álvaro,Esteve Jordi,Carreras Enric,Fernández-Avilés Francesc,Bladé Joan

Funder

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III

Generalitat de Catalunya

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0447-y.pdf

Reference43 articles.

1. Kyle RA. Amyloidosis. Circulation. 1995;91:1269–71.

2. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–96. https://doi.org/10.1056/NEJMra023144 .

3. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59.

4. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2004;104:1881–7. https://doi.org/10.1182/blood-2004-01-0390 .

5. Palladini G, Perfetti V, Obici L, Caccialanza R, Semino A, Adami F, et al. Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Blood. 2004;103:2936–8. https://doi.org/10.1182/blood-2003-08-2788 .

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

2. AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management;Annals of the Academy of Medicine, Singapore;2023-11-29

3. Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis;Transplantation and Cellular Therapy;2021-07

4. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update;Mayo Clinic Proceedings;2021-06

5. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever;PLOS ONE;2020-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3